Injectables refer to drug delivery system which acts as an alternative to oral drugs. As injectables are rapidly inserted into the human body using a syringe, they bypass the first-pass metabolism. In tablet form, some of the drugs become ineffective as they get dismantled in the stomach owing to the digestive enzymes. Generic injectables are pharmaceutical drugs that are bio-equivalent of a branded injectable in terms of dosage, strength, performance, intended use, side-effects and route of administration. This report aims to provide a comprehensive presentation of the global market for Hospital Injectable Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital Injectable Drugs. This report contains market size and forecasts of Hospital Injectable Drugs in global, including the following market information: Global Hospital Injectable Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions) Global top five companies in 2022 (%) The global Hospital Injectable Drugs market was valued at US$ 41580 million in 2022 and is projected to reach US$ 56940 million by 2029, at a CAGR of 4.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. In 2019, North America held the main share in global hospital injectable drugs market,with the propotion of 35%,Europe followed loosely ,at the propotion of 33%. Hospira (Pfizer Inc.) occupied the biggest global hospital injectable drugs market share(13%), Fresenius Kabi followed closely at the propotion of 13%, Baxter and Sichuan Kelun Pharmaceutical also played a virtal role in the market. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hospital Injectable Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Hospital Injectable Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions) Global Hospital Injectable Drugs Market Segment Percentages, by Type, 2022 (%) Generic Sterile Injectables Sterile Intravenous (IV) Solutions Global Hospital Injectable Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions) Global Hospital Injectable Drugs Market Segment Percentages, by Application, 2022 (%) Oncology Anesthesia Anti-Infectives Parenteral Nutrition Cardiovascular Diseases Global Hospital Injectable Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) Global Hospital Injectable Drugs Market Segment Percentages, By Region and Country, 2022 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Hospital Injectable Drugs revenues in global market, 2018-2023 (estimated), ($ millions) Key companies Hospital Injectable Drugs revenues share in global market, 2022 (%) Further, the report presents profiles of competitors in the market, key players include: Hospira (Pfizer Inc.) Baxter Fresenius Kabi Sandoz (Novartis) Hikma Pharmaceuticals PLC Dr. Reddyﾒs Laboratories Ltd Grifols Nichi-Iko Group (Sagent) Teva Pharmaceutical Otsuka B.Braun JW Life Science Auromedics Sanofi Gland Pharma Endo International PLC Sichuan Kelun Pharmaceutical Cisen Pharmaceutical Shijiazhuang No. 4 Pharmaceutical Shandong Hualu Pharmaceutical CR Double-Crane Outline of Major Chapters: Chapter 1: Introduces the definition of Hospital Injectable Drugs, market overview. Chapter 2: Global Hospital Injectable Drugs market size in revenue. Chapter 3: Detailed analysis of Hospital Injectable Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of Hospital Injectable Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports 1.1 Hospital Injectable Drugs Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Hospital Injectable Drugs Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process
